Preclinical NCI-MPACT: prospective modeling of the mutation-based NCI-MPACT clinical trial therapeutic strategy in patient-derived xenograft models

This prospective preclinical study confirmed the modest response rates in the NCI-MPACT clinical trial. Substantial responses to temozolomide suggest that this drug represents an effective treatment for patients with MGMT deficiency, regardless of cancer type.

Authors

Institutions

Publication Details

Journal
Frontiers in Oncology
Published
2025-05-19
DOI
https://doi.org/10.3389/fonc.2025.1571635
Citations
1
Primary Topic
Glioma Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
1.63

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Preclinical NCI-MPACT: prospective modeling of the mutation-based NCI-MPACT clinical trial therapeutic strategy in patient-derived xenograft models

Laura Kuhlmann, Shivaani Kummar, Alice P. Chen, Ming‐Chung Li et al.
1 citations
Frontiers in Oncology
Glioma Diagnosis and Treatment
1.63
article

Preclinical NCI-MPACT: prospective modeling of the mutation-based NCI-MPACT clinical trial therapeutic strategy in patient-derived xenograft models

Laura Kuhlmann, Shivaani Kummar, Alice P. Chen, Ming‐Chung Li, Sergio Y. Alcoser, Chris Karlovich, Larry Rubinstein, Eric C. Polley, P. Mickey Williams, James H. Doroshow, Yvonne A. Evrard, Vishnuprabha Rahul Kannan, Mel Simpson, Shahanawaz Jiwani, Lindsay Dutko, Yingdong Zhao, Biswajit Das, Melinda G. Hollingshead, Alida Palmisano, Michael E. Mullendore, Li Chen, Chih-Jian Lih, Vivekananda Datta
article en
1 citations

Abstract

This prospective preclinical study confirmed the modest response rates in the NCI-MPACT clinical trial. Substantial responses to temozolomide suggest that this drug represents an effective treatment for patients with MGMT deficiency, regardless of cancer type.

Frontiers in OncologyVol. 15
General Dynamics (United States) (US), Oregon Health & Science University (US), Chicago Department of Public Health (US), University of Chicago (US), Frederick National Laboratory for Cancer Research (US), National Cancer Institute (US), Center for Cancer Research (US)
U.S. Department of Health and Human Services, National Institutes of Health, National Cancer Institute
Good health and well-being
Openalex Percentile: Top 17%
Glioma Diagnosis and Treatment
1.63
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.